U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07116694) titled 'Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder' on July 07.
Brief Summary: This open-label study will utilize treatment with BXCL501 in order to assess the suitability of patient-and lay informant-assessed outcome measures for evaluation of severity of psychomotor agitation episodes in patients with Bipolar Disorders, Schizophrenia, Schizoaffective, and Schizophreniform disorders and correlate them with clinician-assessed ratings.
Study Start Date: June 19
Study Type: INTERVENTIONAL
Condition:
Bipolar I Disorder
Bipolar II Disorder
Schizophrenia
Schizoaffective Disorder
Schi...